Search

Author/Creator Thorwarth, A.

1. PHASE 2 KEYNOTE-667 STUDY OF PEMBROLIZUMAB (PEMBRO) IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA (Chl) AND SLOW EARLY RESPONSE (SER) TO FRONTLINE CHEMOTHERAPY (CHEMO). (October 2022)

Authors:
Vinti, L.; Daw, Stephen; Alvarez, C.; Fagioli, F.; Beishuizen, A.; Michel, G.; Moleti, M.; Cepelova, M.; Thorwarth, A.; Rigaud, C.; de Sabando, D.; Parker, J.; Zhu, Y.; Pillai, P.; Nahar, A.; Mauz-Koerholz, C.
Journal:
Leukemia research
Issue:
Volume 121(2022)Supplement
Page Start:
S33
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN-LABEL, KEYNOTE-667 STUDY. (23rd June 2022)

Authors:
Vinti, L.; Daw, S.; Sabado Alvarez, C.; Fagioli, F.; Beishuizen, A.; Michel, G.; Moleti, M. L.; Cepelova, M.; Thorwarth, A.; Rigaud, C.; Plaza Lopez de Sabando, D.; Landman Parker, J.; Zhu, Y.; Pillai, P.; Nahar, A.; Mauz-Koerholz, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
105
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search